APA (7th ed.) Citation

Majidova, N., Yaslıkaya, S., Mıldanoglu, M. M., Coskun, A., Uzundal, D. E., Sahin, T. K., . . . Kostek, O. (2025, May). Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG). The Turkish Journal of Gastroenterology.

Chicago Style (17th ed.) Citation

Majidova, Nargiz, et al. "Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)." The Turkish Journal of Gastroenterology May. 2025.

MLA (9th ed.) Citation

Majidova, Nargiz, et al. "Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)." The Turkish Journal of Gastroenterology, May. 2025.